WAVERLEY PHARMA INC.

Research WAVERLEY PHARMA INC. (5GZ) on Bullrun: market cap EUR 827.74K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker5GZ
• ExchangeF
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 827.74K
• Financial periodQ3 2025
• RevenueEUR 1.05M
• Net income-EUR 301.91K
• Free cash flow-EUR 138.86K
• Gross margin37.5%

Valuation Snapshot

latest market cap is EUR 827.74K.

About WAVERLEY PHARMA INC.

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops PARP-1 Inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. In addition, it is involved in the sale of prescription medications, over-the-counter products, and associated pharmacy services. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.

Frequently asked questions

What is WAVERLEY PHARMA INC.'s market cap?

WAVERLEY PHARMA INC.'s market capitalization is EUR 827.74K.

What does WAVERLEY PHARMA INC. do?

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops PARP-1 Inhibitors for cancer treatment. It also operates a retail pharmacy in the United States.